Home / Pharma Healthcare / Global Direct-To-Consumer Disease Risk And Health Test Market Size, Status And Forecast 2019-2025

Global Direct-To-Consumer Disease Risk And Health Test Market Size, Status And Forecast 2019-2025

  • Id : RNR-264586
  • Category : Pharma Healthcare
  • Publish Date : Mar-2019
  • Publisher : Research-N-Reports
  • Pages : 123
  • Format : PDF
License Type

Description
The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.
In 2018, the global Direct-to-consumer Disease Risk and Health Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Direct-to-consumer Disease Risk and Health Test development in United States, Europe and China.

The key players covered in this study
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes

Market segment by Type, the product can be split into
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other

Market segment by Application, split into
Online
Offline

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players.
To present the Direct-to-consumer Disease Risk and Health Test development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Direct-to-consumer Disease Risk and Health Test are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.